The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
A quantum state that lasts forever may finally be within our grasp
3
Has the answer to life's origins been hiding in our cells all along?
4
Our brains have their first thoughts surprisingly early in life
5
Most portable air conditioners suck – but there's an easy fix
6
Gas from Uranus reveals it has an icy centre
7
Autism may have two distinct subtypes that vary by brain activity
8
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
9
Carl Sagan's The Demon-Haunted World is still supremely relevant today
10
Why I have changed my mind about AI and you should too
